Analysts have been eager to weigh in on the Healthcare sector with new ratings on Merck & Company (MRK – Research Report), Alibaba Health Information Technology (ALBHF – Resea ...

DARMSTADT, Germany--(BUSINESS WIRE)--July 28, 2005--Merck KGaA announced today that it will provide up-to-date information on its important ongoing clinical studies. It will also disclose information ...

German science and technology company Merck KGaA has launched a supercomputer in Germany. Housed in an Equinix data center in ...

Merck (MRK) ended the recent trading session at $87.61, demonstrating a -1.34% change from the preceding day's closing price. The stock fell short of the S&P 500, which registered a loss of 0.38% for ...

Merck announced April 16 it entered into a definitive agreement to acquire San Diego-based biotechnology company Prometheus Biosciences Inc. for $200 per share in cash, representing a total equity ...

Merck (MRK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Themis, a company focused on vaccines and immune-modulation therapies for infectious ...

WASHINGTON, DC- The Merck Company Foundation and the American Association for the Advancement of Science (AAAS) today announced winners of the 2005 awards for the Merck/AAAS Undergraduate Science ...

KENILWORTH, N.J., Aug. 14, 2020 /PRNewswire/ -- Glaucoma is the second-leading cause of blindness in the United States and around the world, yet an estimated 50 percent of people suffering from ...

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the appointment of Matthew Walsh and Rachel Stahler as Chief Financial Officer and Chief Information Officer, ...

EXZOLT™ CATTLE-CA1 is the first in its class and the only product conditionally approved for both the prevention and treatment of New World screwworm and treatment and control of cattle fever ...

In the latest close session, Merck (MRK) was down 1.04% at $84.81. The stock fell short of the S&P 500, which registered a loss of 0.16% for the day. Meanwhile, the Dow gained 0.44%, and the Nasdaq, a ...